Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy

Thrombosis and Haemostasis

Volumn 86, Issue 6, 2001, Pages 1379-1384

  Pauzner, R ^a   Dulitzki, M ^a   Langevitz, P ^a   Livneh, A ^a   Kenett, R ^a   Many, A ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Antiphospholipid syndrome; Low molecular weight heparin; Pregnancy; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BIRTH RATE; BIRTH WEIGHT; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETOPLACENTAL UNIT; FETUS DISEASE; HUMAN; INCIDENCE; INFORMED CONSENT; MATERNAL DISEASE; MATERNAL TREATMENT; MEDICAL DECISION MAKING; MORBIDITY; NEUROLOGIC DISEASE; NEWBORN HEMORRHAGIC DISEASE; PREECLAMPSIA; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; PUERPERIUM; TERATOGENICITY; THROMBOSIS; TREATMENT OUTCOME;

EID: 0035652633     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616739     Document Type: Article

References (55)

1. The antiphospholipid syndrome: Ten years on
2. The immunobiology and obstetrical consequences of antiphospholipid antibodies
3. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population
4. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies
5. Obstetric complications associated with the lupus anticoagulant
6. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy
7. The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction
8. Preeclampsia and liver infarction in early pregnancy associated with antiphospholipid syndrome
9. Lupus anticoagulant and HELLP syndrome complicated by placental abruption, hepatic, dermal and adrenal infarction
10. An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy; A report of 2 cases
11. An acute disseminated coagulopathy-vasculopathy associated with the antiphospholipid syndrome
12. Histopathological findings in placentae from patients with intra-uterine fetal death and antiphospholipid antibodies
13. Pregnancy loss in the antiphospholipid antibody syndrome - A possible thrombogenic mechanism
14. Antiphospholipid antibodies and thrombotic predisposition: Underlying pathogenic mechanisms
15. Antiphospholipid antibodies and thrombosis
16. Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts
17. IgM antitrophoblast antibodies in a patient with a pregnancy-associated lupus-like disorder, vasculitis and recurrent intrauterine fetal demise
18. Haemostasis in normal pregnancy
19. Activated protein C sensitivity, protein C, protein S, and coagulation in normal pregnancy
20. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy
21. Fetal survival after prednisone suppression of maternal lupus-anticoagulant
22. Fetal loss treatment in patients with antiphospholipid antibodies
23. Prevention of anticardiolipin antibody related pregnancy losses with prednisone and aspirin
24. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody positive obstetric patients
25. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies
26. Treatment of patients with antiphospholipid antibodies during pregnancy
27. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative trial comparing prednisone with low dose heparin treatment
28. A study of sixty pregnancies in patients with the antiphospholipid syndrome
29. Antiphospholipid antibody associated recurrent pregnancy loss: Treatment with heparin and low dose aspirin is superior to low dose aspirin alone
30. A prospective study of fifty-three consecutive calcium heparin treated pregnancies in patients with antiphospholipid antibody-related fetal loss
31. Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
32. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin
33. Antiphospholipid antibodies and reproduction: The antiphospholipid antibody syndrome
34. Use of antithrombotic agents during pregnancy
35. Guidelines on the investigation and management of the antiphospholipid syndrome
36. Low molecular weight heparin during pregnancy
37. Anticoagulants in pregnancy
38. Anticoagulant therapy in pregnancy: Report of 54 cases
39. Anticoagulants and thrombolytics during pregnancy
40. Outcome of pregnancy in women with valve prostheses
41. Anticoagulation of women with prosthetic heart valves during pregnancy
42. Thromboprophylaxis in antiphospholipid syndrome pregnancies with previous cerebral arterial thrombotic events: Is warfarin preferable?
43. Antiaggregating and anticoagulant therapy in systemic lupus erythematosus and Hughes' syndrome
44. Heparin
45. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses
46. Safety of low- molecular weight heparin in pregnancy: A systematic review
47. Low-molecular weight heparins in pregnancy
48. Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin
49. Osteoporosis and vertebral collapse following low-dose, low molecular weight heparin therapy in a young patient
50. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies
51. Detection and quantitative evaluation of Lupus circulating anticoagulant activity
52. Use of low molecular weight heparin in pregnancy
53. Low molecular weight heparin during pregnancy and delivery: Preliminary experience with 41 pregnancies
54. Low molecular weight heparin for obstetrics thromboprophylaxis: Experience of sixty-nine pregnancies in sixty-one women at high risk
55. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin